CIA SANEAMENTO BASICO DE-ADR (SBS) Fundamental Analysis & Valuation

NYSE:SBS • US20441A1025

Current stock price

33.49 USD
-0.52 (-1.53%)
Last:

This SBS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. SBS Profitability Analysis

1.1 Basic Checks

  • In the past year SBS was profitable.
  • SBS had a positive operating cash flow in the past year.
  • In the past 5 years SBS has always been profitable.
  • Each year in the past 5 years SBS had a positive operating cash flow.
SBS Yearly Net Income VS EBIT VS OCF VS FCFSBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • The Return On Assets of SBS (8.12%) is better than 92.86% of its industry peers.
  • With an excellent Return On Equity value of 19.96%, SBS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • SBS has a Return On Invested Capital of 10.21%. This is amongst the best in the industry. SBS outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SBS is significantly above the industry average of 4.59%.
Industry RankSector Rank
ROA 8.12%
ROE 19.96%
ROIC 10.21%
ROA(3y)8.56%
ROA(5y)7.1%
ROE(3y)19.23%
ROE(5y)15.67%
ROIC(3y)11.56%
ROIC(5y)9.45%
SBS Yearly ROA, ROE, ROICSBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With a decent Profit Margin value of 22.21%, SBS is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • SBS's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 32.95%, SBS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SBS has grown nicely.
  • SBS has a Gross Margin (36.77%) which is in line with its industry peers.
  • SBS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 32.95%
PM (TTM) 22.21%
GM 36.77%
OM growth 3Y16.29%
OM growth 5Y5.54%
PM growth 3Y16.22%
PM growth 5Y32.36%
GM growth 3Y2.08%
GM growth 5Y0.01%
SBS Yearly Profit, Operating, Gross MarginsSBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

5

2. SBS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SBS is destroying value.
  • The number of shares outstanding for SBS has been reduced compared to 1 year ago.
  • SBS has less shares outstanding than it did 5 years ago.
  • SBS has a worse debt/assets ratio than last year.
SBS Yearly Shares OutstandingSBS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SBS Yearly Total Debt VS Total AssetsSBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SBS has an Altman-Z score of 2.26. This is not the best score and indicates that SBS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 2.26, SBS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • A Debt/Equity ratio of 0.83 indicates that SBS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.83, SBS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Altman-Z 2.26
ROIC/WACC0.86
WACC11.91%
SBS Yearly LT Debt VS Equity VS FCFSBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B

2.3 Liquidity

  • SBS has a Current Ratio of 1.12. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
  • SBS has a Current ratio of 1.12. This is in the better half of the industry: SBS outperforms 64.29% of its industry peers.
  • SBS has a Quick Ratio of 1.12. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.12, SBS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
SBS Yearly Current Assets VS Current LiabilitesSBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

5

3. SBS Growth Analysis

3.1 Past

  • SBS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.13%.
  • SBS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 55.40% yearly.
  • Looking at the last year, SBS shows a small growth in Revenue. The Revenue has grown by 5.39% in the last year.
  • The Revenue has been growing by 16.44% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.13%
EPS 3Y41.32%
EPS 5Y55.4%
EPS Q2Q%110.53%
Revenue 1Y (TTM)5.39%
Revenue growth 3Y19.98%
Revenue growth 5Y16.44%
Sales Q2Q%43.85%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.19% on average over the next years.
  • Based on estimates for the next years, SBS will show a quite strong growth in Revenue. The Revenue will grow by 11.98% on average per year.
EPS Next Y-15.89%
EPS Next 2Y6.77%
EPS Next 3Y-2.19%
EPS Next 5YN/A
Revenue Next Year12.14%
Revenue Next 2Y14.18%
Revenue Next 3Y11.72%
Revenue Next 5Y11.98%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SBS Yearly Revenue VS EstimatesSBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
SBS Yearly EPS VS EstimatesSBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. SBS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.67, the valuation of SBS can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of SBS indicates a rather cheap valuation: SBS is cheaper than 100.00% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of SBS to the average of the S&P500 Index (27.38), we can say SBS is valued rather cheaply.
  • SBS is valuated correctly with a Price/Forward Earnings ratio of 16.23.
  • Based on the Price/Forward Earnings ratio, SBS is valued cheaper than 92.86% of the companies in the same industry.
  • SBS is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.67
Fwd PE 16.23
SBS Price Earnings VS Forward Price EarningsSBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBS indicates a rather cheap valuation: SBS is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.65
SBS Per share dataSBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • SBS has an outstanding profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as SBS's earnings are expected to decrease with -2.19% in the coming years.
PEG (NY)N/A
PEG (5Y)0.25
EPS Next 2Y6.77%
EPS Next 3Y-2.19%

3

5. SBS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.73%, SBS is not a good candidate for dividend investing.
  • SBS's Dividend Yield is slightly below the industry average, which is at 2.92.
  • With a Dividend Yield of 0.73, SBS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.73%

5.2 History

  • On average, the dividend of SBS grows each year by 20.89%, which is quite nice.
  • SBS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SBS has decreased its dividend recently.
Dividend Growth(5Y)20.89%
Div Incr Years1
Div Non Decr Years1
SBS Yearly Dividends per shareSBS Yearly Dividends per shareYearly Dividends per share 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • SBS pays out 27.93% of its income as dividend. This is a sustainable payout ratio.
DP27.93%
EPS Next 2Y6.77%
EPS Next 3Y-2.19%
SBS Yearly Income VS Free CF VS DividendSBS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B
SBS Dividend Payout.SBS Dividend Payout, showing the Payout Ratio.SBS Dividend Payout.PayoutRetained Earnings

SBS Fundamentals: All Metrics, Ratios and Statistics

CIA SANEAMENTO BASICO DE-ADR

NYSE:SBS (4/16/2026, 2:27:07 PM)

33.49

-0.52 (-1.53%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryWater Utilities
Earnings (Last)03-15
Earnings (Next)05-07
Inst Owners62.37%
Inst Owner Change-0.01%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.12B
Revenue(TTM)38.09B
Net Income(TTM)8.46B
Analysts84.76
Price Target32.11 (-4.12%)
Short Float %N/A
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield 0.73%
Yearly Dividend0.65
Dividend Growth(5Y)20.89%
DP27.93%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.19%
Min EPS beat(2)63.52%
Max EPS beat(2)82.86%
EPS beat(4)4
Avg EPS beat(4)57.99%
Min EPS beat(4)5.76%
Max EPS beat(4)82.86%
EPS beat(8)6
Avg EPS beat(8)77.52%
EPS beat(12)8
Avg EPS beat(12)51.19%
EPS beat(16)10
Avg EPS beat(16)44.27%
Revenue beat(2)2
Avg Revenue beat(2)65.23%
Min Revenue beat(2)40.42%
Max Revenue beat(2)90.03%
Revenue beat(4)4
Avg Revenue beat(4)46.15%
Min Revenue beat(4)23.03%
Max Revenue beat(4)90.03%
Revenue beat(8)8
Avg Revenue beat(8)47.19%
Revenue beat(12)12
Avg Revenue beat(12)36.71%
Revenue beat(16)16
Avg Revenue beat(16)32.37%
PT rev (1m)9.07%
PT rev (3m)15.49%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)-2.47%
EPS NY rev (1m)0.69%
EPS NY rev (3m)-8.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 13.67
Fwd PE 16.23
P/S 3.16
P/FCF N/A
P/OCF 14.42
P/B 2.84
P/tB N/A
EV/EBITDA 9.65
EPS(TTM)2.45
EY7.32%
EPS(NY)2.06
Fwd EY6.16%
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)2.32
OCFY6.94%
SpS10.58
BVpS11.78
TBVpS-2.25
PEG (NY)N/A
PEG (5Y)0.25
Graham Number25.4825 (-23.91%)
Profitability
Industry RankSector Rank
ROA 8.12%
ROE 19.96%
ROCE 14.32%
ROIC 10.21%
ROICexc 11.88%
ROICexgc 36.09%
OM 32.95%
PM (TTM) 22.21%
GM 36.77%
FCFM N/A
ROA(3y)8.56%
ROA(5y)7.1%
ROE(3y)19.23%
ROE(5y)15.67%
ROIC(3y)11.56%
ROIC(5y)9.45%
ROICexc(3y)12.75%
ROICexc(5y)10.35%
ROICexgc(3y)57.47%
ROICexgc(5y)49.95%
ROCE(3y)16.22%
ROCE(5y)13.25%
ROICexgc growth 3Y-5.57%
ROICexgc growth 5Y-6.54%
ROICexc growth 3Y19.26%
ROICexc growth 5Y8.67%
OM growth 3Y16.29%
OM growth 5Y5.54%
PM growth 3Y16.22%
PM growth 5Y32.36%
GM growth 3Y2.08%
GM growth 5Y0.01%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Debt/EBITDA 2.37
Cap/Depr 622.09%
Cap/Sales 36.07%
Interest Coverage 4.66
Cash Conversion 56.65%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 2.26
F-Score4
WACC11.91%
ROIC/WACC0.86
Cap/Depr(3y)356.81%
Cap/Depr(5y)276.92%
Cap/Sales(3y)24.82%
Cap/Sales(5y)22.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.13%
EPS 3Y41.32%
EPS 5Y55.4%
EPS Q2Q%110.53%
EPS Next Y-15.89%
EPS Next 2Y6.77%
EPS Next 3Y-2.19%
EPS Next 5YN/A
Revenue 1Y (TTM)5.39%
Revenue growth 3Y19.98%
Revenue growth 5Y16.44%
Sales Q2Q%43.85%
Revenue Next Year12.14%
Revenue Next 2Y14.18%
Revenue Next 3Y11.72%
Revenue Next 5Y11.98%
EBIT growth 1Y-18.89%
EBIT growth 3Y39.53%
EBIT growth 5Y22.89%
EBIT Next Year40.19%
EBIT Next 3Y25.04%
EBIT Next 5Y20.06%
FCF growth 1Y-759.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.92%
OCF growth 3Y28.21%
OCF growth 5Y10.93%

CIA SANEAMENTO BASICO DE-ADR / SBS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CIA SANEAMENTO BASICO DE-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to SBS.


Can you provide the valuation status for CIA SANEAMENTO BASICO DE-ADR?

ChartMill assigns a valuation rating of 5 / 10 to CIA SANEAMENTO BASICO DE-ADR (SBS). This can be considered as Fairly Valued.


What is the profitability of SBS stock?

CIA SANEAMENTO BASICO DE-ADR (SBS) has a profitability rating of 8 / 10.


What are the PE and PB ratios of CIA SANEAMENTO BASICO DE-ADR (SBS) stock?

The Price/Earnings (PE) ratio for CIA SANEAMENTO BASICO DE-ADR (SBS) is 13.67 and the Price/Book (PB) ratio is 2.84.


Can you provide the expected EPS growth for SBS stock?

The Earnings per Share (EPS) of CIA SANEAMENTO BASICO DE-ADR (SBS) is expected to decline by -15.89% in the next year.